Virtual manufacturing models and the power of the cloud

With ever-increasing pressure among life science companies to develop treatments and medicines faster, more and more are outsourcing many of their core business processes.

During the past few years, this has given way to the growing popularity of virtual pharmaceutical models wherein companies rely extensively on external capabilities, especially for manufacturing.

In fact, virtual companies have become a major presence in the industry, developing more of the new drugs in the pipeline than many former blockbuster drug companies.¹